Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO)
OBIO Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-15.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
76.20%
OBIO Stock Analysis
OBIO
PE Ratio:
OBIO
PEG Ratio:
Not Available
OBIO
Forward EPS Growth (12 month):
0.00%
OBIO
PS Ratio:
7.1
OBIO
PSG Ratio:
-0.7
OBIO
Forward Revenue Growth (12 month):
-10.20%
OBIO Articles
No data was found